Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 185

1.

Summary of the 2015 Purine and Pyrimidine Society/Purine Metabolic Patients Association H. Anne Simmonds Memorial Lecture.

Becker MA.

Nucleosides Nucleotides Nucleic Acids. 2016 Dec;35(10-12):502-506. No abstract available.

PMID:
27906633
2.

In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma.

AlHilli MM, Becker MA, Weroha SJ, Flatten KS, Hurley RM, Harrell MI, Oberg AL, Maurer MJ, Hawthorne KM, Hou X, Harrington SC, McKinstry S, Meng XW, Wilcoxen KM, Kalli KR, Swisher EM, Kaufmann SH, Haluska P.

Gynecol Oncol. 2016 Nov;143(2):379-388. doi: 10.1016/j.ygyno.2016.08.328.

PMID:
27614696
3.

Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer.

Becker MA, Hou X, Tienchaianada P, Haines BB, Harrington SC, Weroha SJ, Sathyanarayanan S, Haluska P.

BMC Cancer. 2016 Oct 20;16(1):814.

4.

Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study).

Saag KG, Fitz-Patrick D, Kopicko J, Fung M, Bhakta N, Adler S, Storgard C, Baumgartner S, Becker MA.

Arthritis Rheumatol. 2017 Jan;69(1):203-212. doi: 10.1002/art.39840.

PMID:
27564409
5.

Risk of Early Rehospitalization for Non-Behavioral Health Conditions Among Adult Medicaid Beneficiaries with Severe Mental Illness or Substance Use Disorders.

Becker MA, Boaz TL, Andel R, Hafner S.

J Behav Health Serv Res. 2017 Jan;44(1):113-121. doi: 10.1007/s11414-016-9516-9.

PMID:
27270399
6.

Insulin Receptor Substrate Adaptor Proteins Mediate Prognostic Gene Expression Profiles in Breast Cancer.

Becker MA, Ibrahim YH, Oh AS, Fagan DH, Byron SA, Sarver AL, Lee AV, Shaw LM, Fan C, Perou CM, Yee D.

PLoS One. 2016 Mar 18;11(3):e0150564. doi: 10.1371/journal.pone.0150564.

7.

Impact of Febuxostat on Renal Function in Gout Patients With Moderate-to-Severe Renal Impairment.

Saag KG, Whelton A, Becker MA, MacDonald P, Hunt B, Gunawardhana L.

Arthritis Rheumatol. 2016 Aug;68(8):2035-43. doi: 10.1002/art.39654.

PMID:
26894653
8.

The Art and Science of Learning, Teaching, and Delivering Feedback in Psychosomatic Medicine.

Lokko HN, Gatchel JR, Becker MA, Stern TA.

Psychosomatics. 2016 Jan-Feb;57(1):31-40. doi: 10.1016/j.psym.2015.09.006. Review.

PMID:
26683348
9.

Rehospitalization risk factors for psychiatric treatment among elderly Medicaid beneficiaries following hospitalization for a physical health condition.

Boaz TL, Becker MA, Andel R, McCutchan N.

Aging Ment Health. 2017 Mar;21(3):297-303. doi: 10.1080/13607863.2015.1104532.

PMID:
26523783
10.

Inflammation: a possible mechanism for a causative role of hyperuricemia/gout in cardiovascular disease.

Perez-Ruiz F, Becker MA.

Curr Med Res Opin. 2015;31 Suppl 2:9-14. doi: 10.1185/03007995.2015.1087980. Review.

PMID:
26414731
11.

An open-label, 6-month study of allopurinol safety in gout: The LASSO study.

Becker MA, Fitz-Patrick D, Choi HK, Dalbeth N, Storgard C, Cravets M, Baumgartner S.

Semin Arthritis Rheum. 2015 Oct;45(2):174-83. doi: 10.1016/j.semarthrit.2015.05.005.

12.

Conventional chemotherapy and oncogenic pathway targeting in ovarian carcinosarcoma using a patient-derived tumorgraft.

Glaser G, Weroha SJ, Becker MA, Hou X, Enderica-Gonzalez S, Harrington SC, Haluska P.

PLoS One. 2015 May 11;10(5):e0126867. doi: 10.1371/journal.pone.0126867.

13.

Differences between winter oilseed rape (Brassica napus L.) cultivars in nitrogen starvation-induced leaf senescence are governed by leaf-inherent rather than root-derived signals.

Koeslin-Findeklee F, Becker MA, van der Graaff E, Roitsch T, Horst WJ.

J Exp Bot. 2015 Jul;66(13):3669-81. doi: 10.1093/jxb/erv170.

14.

Transcriptomic analysis of nitrogen starvation- and cultivar-specific leaf senescence in winter oilseed rape (Brassica napus L.).

Koeslin-Findeklee F, Rizi VS, Becker MA, Parra-Londono S, Arif M, Balazadeh S, Mueller-Roeber B, Kunze R, Horst WJ.

Plant Sci. 2015 Apr;233:174-85. doi: 10.1016/j.plantsci.2014.11.018.

PMID:
25711825
15.

A novel neutralizing antibody targeting pregnancy-associated plasma protein-a inhibits ovarian cancer growth and ascites accumulation in patient mouse tumorgrafts.

Becker MA, Haluska P Jr, Bale LK, Oxvig C, Conover CA.

Mol Cancer Ther. 2015 Apr;14(4):973-81. doi: 10.1158/1535-7163.MCT-14-0880.

16.

Infusion-related reactions with pegloticase, a recombinant uricase for the treatment of chronic gout refractory to conventional therapy.

Baraf HS, Yood RA, Ottery FD, Sundy JS, Becker MA.

J Clin Rheumatol. 2014 Dec;20(8):427-32. doi: 10.1097/RHU.0000000000000200. Review.

17.

Urate transporters: transforming the face of hyperuricemia and gout.

Becker MA, Simkin PA, Sorensen LB.

J Rheumatol. 2014 Oct;41(10):1910-2. doi: 10.3899/jrheum.141019. No abstract available.

PMID:
25179848
18.

How Does a SILAR CdSe Film Grow? Tuning the Deposition Steps to Suppress Interfacial Charge Recombination in Solar Cells.

Becker MA, Radich JG, Bunker BA, Kamat PV.

J Phys Chem Lett. 2014 May 1;5(9):1575-82. doi: 10.1021/jz500481v.

PMID:
26270098
19.

Long-term management of gout: nonpharmacologic and pharmacologic therapies.

Chaichian Y, Chohan S, Becker MA.

Rheum Dis Clin North Am. 2014 May;40(2):357-74. doi: 10.1016/j.rdc.2014.01.012. Review.

PMID:
24703352
20.

Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout.

Lipsky PE, Calabrese LH, Kavanaugh A, Sundy JS, Wright D, Wolfson M, Becker MA.

Arthritis Res Ther. 2014 Mar 4;16(2):R60. doi: 10.1186/ar4497.

Supplemental Content

Loading ...
Support Center